Menu Menu

News

Featured
COVID-19 Research Pipeline

173,472

Registered/ Published

4,478

Registered

715

Published

6,738

Registered
As at 30 September 2022
FILTERED BY > Children and adolescents Clear filter

Communique #65

9 May, 2022
Click for the latest Taskforce news:
Communique

Communique #61

25 March, 2022
Click for the latest Taskforce news: 
Communique

Communique #59

7 March, 2022
Click for the latest Taskforce news:
Communique

Communique #58

18 February, 2022
Click for the latest Taskforce news:
Communique

Communique #54

26 November, 2021
Click for the latest Taskforce news:
Communique

Communique #51

15 October, 2021
WEEK IN REVIEW Updates to the Living Treatment Guidelines New recommendations New recommendation for Continuous positive airway pressure / High-flow nasal oxygen therapy The Hospital and Acute Care...
Communique

Communique #40

18 March, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE New recommendation for tocilizumab in children or adolescents Further to the Taskforce's recent recommendation for the conditional use of tocilizumab for adults (25...
Communique

Weekly Communique #33

26 November, 2020
WEEK IN REVIEW Updates to the living guideline Three new recommendations have been published this week covering: Bamlanivimab Fluvoxamine Intravenous immunoglobulin VTE prophylaxis for children and adolescents Further details are...
Communique

Weekly Communique #32

19 November, 2020
WEEK IN REVIEW BREAKING NEWS: Australian-led REMAP-CAP Trial reports benefit of tocilizumab for critically ill patients with COVID-19. The REMAP-CAP investigators led by Prof Steve Webb, Monash University, have this...
Communique

Weekly Communique #21

3 September, 2020
WEEK IN REVIEW New recommendations for children and adolescents, and pregnant women The Paediatric and Adolescent Care Panel have developed two new consensus recommendations for respiratory support covering...
Communique

Weekly Communique #19

20 August, 2020
WEEK IN REVIEW New recommendations for Child and Adolescent Care It has been a busy week for the Child and Adolescent Care Panel with two new consensus recommendations...
Communique

Weekly Communique #18

13 August, 2020
WEEK IN REVIEW New pregnancy and perinatal care recommendation: Skin-to-skin contact This week the Pregnancy and Perinatal Care Panel made a consensus recommendation on skin-to-skin contact between parent...
Communique

Weekly Communique #17

6 August, 2020
WEEK IN REVIEW 'Do not use': The Taskforce has strengthened its recommendation against the use of hydroxychloroquine as a treatment for COVID-19 This week the Taskforce upgraded the strength...
Communique

Weekly Communique #16

30 July, 2020
Dear colleagues, On behalf of all members of the Taskforce, we would like to take this opportunity to acknowledge our Victorian colleagues caring for people with COVID-19 during...
Communique

Weekly Communique #14

16 July, 2020
WEEK IN REVIEW This week we experienced a shift in the level of alert among the clinicians who form Australia's frontline healthcare response to COVID-19, particularly in Victoria....
Communique

Weekly Communique #11

25 June, 2020
WEEK IN REVIEW Dexamethasone now under review by the Taskforce Following Tuesday's (23 June) pre-print release of results of the dexamethesaone arm of the UK's RECOVERY study, the...
Communique

Weekly Communique #9

11 June, 2020
WEEK IN REVIEW Time to acknowledge our expert volunteer contributions It's hard to believe that it's been 12 weeks since the Taskforce's first panel meeting. What began with...
Communique